Streetbeat News

Analyst Ratings

META

Piper Sandler analyst Thomas Champion has maintained an Overweight rating on Meta Platforms (NASDAQ:META) but lowered the price target from $365 to $355.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 4:37 pm

FBNC

Piper Sandler analyst Stephen Scouten maintains an Overweight rating on First Bancorp (NASDAQ:FBNC) but lowers the price target from $34 to $32.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 4:34 pm

WSFS

Piper Sandler analyst Frank Schiraldi has maintained a Neutral rating on WSFS Financial (NASDAQ:WSFS) and raised the price target from $37 to $38.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 4:33 pm

ENPH

SEDG

Enphase Energy (ENPH) is set to report its Q3 earnings after market close on Thursday. The company's stock has declined by almost 62% YTD, impacted by rival SolarEdge Technology's (SEDG) stagnant European sales. Analysts expect ENPH to report $1.03 in EPS for the quarter and $566.02 million in revenue. The consensus price target stands at $180.58 a share, representing a significant upside from current price levels. ENPH's shares are down almost 20% over the past month, trading at $96.16 at the time of publication.

Portfolio Pulse from Surbhi Jain

October 26, 2023 | 4:31 pm

BUSE

Piper Sandler analyst Andrew Liesch maintains an Overweight rating on First Busey (NASDAQ:BUSE) but lowers the price target from $22 to $21.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 4:30 pm

GPCR

Piper Sandler analyst Yasmeen Rahimi maintains an Overweight rating on Structure Therapeutics (NASDAQ:GPCR) and raises the price target from $58 to $93.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 4:28 pm

EW

Piper Sandler analyst Adam Maeder has maintained a Neutral rating on Edwards Lifesciences (NYSE:EW) and lowered the price target from $83 to $68.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 4:26 pm

HCSG

Benchmark analyst Bill Sutherland maintains a Buy rating on Healthcare Services Group (NASDAQ:HCSG) but lowers the price target from $18 to $16.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 4:23 pm

STE

Piper Sandler analyst Jason Bednar maintains a Neutral rating on Steris (NYSE:STE) and lowers the price target from $220 to $215.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 4:20 pm

AMD

GOOG

INTC

META

MSFT

NVDA

Nvidia Corp's stock is experiencing a selloff following the U.S.'s early implementation of an export embargo on artificial intelligence chips. China accounts for 20%-25% of Nvidia's data center revenues. Despite this, CNBC's Jim Cramer remains optimistic about Nvidia due to increasing demand from Alphabet Inc and Microsoft Corp. The sanctions are expected to increase competition in the U.S., potentially affecting Advanced Micro Devices, Inc and Intel Corp. Nvidia is developing CPUs to support Microsoft's Windows operating system. Lackluster earnings results from Wall Street and Meta Platforms Inc's Q3 revenue report also impacted the stock.

Portfolio Pulse from Anusuya Lahiri

October 26, 2023 | 4:18 pm